Understand the source comparison
GHRP-6 Acetate: Research Application Comparison
Before selecting GHRP-6 Acetate for a research protocol, understanding how it compares to other growth hormone secretagogues clarifies where it provides distinct advantages and where alternative peptides may better serve specific experimental designs. GHRP-6 A
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting GHRP-6 Acetate for a research protocol, understanding how it compares to other growth hormone secretagogues clarifies where it provides distinct advantages and where alternative peptides may better serve specific experimental designs.
- GHRP-6 Acetate
- GHS-R1a (ghrelin receptor)
- Moderate (18–25 ng/mL peak at 1 mcg/kg)
- Strong stimulation
- 20–30 minutes
- Best for studies requiring appetite co-measurement or examining ghrelin pathway interaction—synergistic with GHRH
- GHRP-2
- GHS-R1a
- High (25–35 ng/mL peak at 1 mcg/kg)
- Minimal
- Higher GH output than GHRP-6 without appetite confound—preferred for pure GH dynamics research
- Ipamorelin
- GHS-R1a (selective)
- Moderate (15–22 ng/mL peak at 1 mcg/kg)
- None
- 2 hours
- Longest half-life among GHRPs—ideal for once-daily dosing protocols; lowest side effect profile
- Hexarelin
- Very high (40–50 ng/mL peak at 2 mcg/kg)
- Moderate
- 70 minutes
- Most potent GH release but shows receptor desensitization with chronic use—suitable for acute studies only
- CJC-1295 (no DAC)
- GHRH receptor
- Sustained elevation (10–18 ng/mL for 6–8 hours)
- 30 minutes (half-life); 6–8 hour duration
- Amplifies natural GH pulses rather than creating discrete peaks—works synergistically with GHRPs
- MK-677 (Ibutamoren)
- Sustained (15–25 ng/mL for 24 hours)
- 24 hours
- Oral bioavailability makes it unique—chronic elevation rather than pulsatile; not suitable for pulse-pattern research
- The bottom line: GHRP-6 is the only peptide in this comparison that directly stimulates both GH secretion and appetite through the ghrelin receptor, making it irreplaceable for research models examining the GH-ghrelin-metabolism axis. If appetite stimulation is a confounding variable rather than a research target, Ghrp 2 or Ipamorelin provide cleaner GH-specific data.